|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
11.16(B) |
Last
Volume: |
762,316 |
Avg
Vol: |
474,459 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
5 |
Total Shares Sold |
6,002 |
31,084 |
49,996 |
92,833 |
Total Sell Value |
$1,524,396 |
$7,621,206 |
$11,292,577 |
$21,658,880 |
Total People Sold |
3 |
6 |
6 |
8 |
Total Sell Transactions |
5 |
11 |
16 |
28 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2021-02-25 |
4 |
OE |
$88.05 |
$242,138 |
D/D |
2,750 |
19,996 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2021-02-24 |
4 |
D |
$282.98 |
$91,120 |
D/D |
(322) |
17,246 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2021-02-24 |
4 |
D |
$282.98 |
$91,120 |
D/D |
(322) |
4,975 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2021-02-24 |
4 |
AS |
$279.51 |
$6,836,607 |
D/D |
(24,009) |
221,151 |
|
31% |
|
Foster James C |
Chairman, President and CEO |
|
2021-02-24 |
4 |
OE |
$88.05 |
$2,113,992 |
D/D |
24,009 |
245,160 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2021-02-24 |
4 |
D |
$282.98 |
$625,386 |
D/D |
(2,210) |
221,151 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2021-02-24 |
4 |
D |
$282.98 |
$81,781 |
D/D |
(289) |
16,862 |
|
- |
|
Girshick Birgit |
Corporate Executive VP |
|
2021-02-24 |
4 |
D |
$282.98 |
$91,120 |
D/D |
(322) |
29,060 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2021-02-23 |
4/A |
D |
$283.59 |
$68,629 |
D/D |
(242) |
17,151 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2021-02-23 |
4 |
D |
$283.59 |
$89,331 |
D/D |
(315) |
5,297 |
|
- |
|
Chubb Stephen D |
Director |
|
2021-02-23 |
4 |
S |
$281.66 |
$185,330 |
D/D |
(658) |
40,529 |
|
-32% |
|
Chubb Stephen D |
Director |
|
2021-02-23 |
4 |
OE |
$52.29 |
$184,584 |
D/D |
3,530 |
41,187 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2021-02-23 |
4 |
AS |
$274.81 |
$5,678,578 |
D/D |
(20,295) |
223,361 |
|
32% |
|
Foster James C |
Chairman, President and CEO |
|
2021-02-23 |
4 |
OE |
$109.34 |
$2,219,055 |
D/D |
20,295 |
243,656 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2021-02-23 |
4 |
D |
$283.59 |
$565,478 |
D/D |
(1,994) |
223,361 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2021-02-23 |
4 |
D |
$283.59 |
$89,331 |
D/D |
(315) |
17,568 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2021-02-23 |
4 |
D |
$283.59 |
$23,822 |
D/D |
(84) |
4,052 |
|
- |
|
Girshick Birgit |
Corporate Executive VP |
|
2021-02-23 |
4 |
D |
$283.59 |
$89,331 |
D/D |
(315) |
29,382 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2021-02-23 |
4 |
D |
$283.59 |
$77,136 |
D/D |
(272) |
17,031 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2021-02-22 |
4/A |
D |
$289.55 |
$45,459 |
D/D |
(157) |
17,393 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2021-02-22 |
4 |
D |
$289.55 |
$83,101 |
D/D |
(287) |
5,612 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2021-02-22 |
4 |
D |
$289.55 |
$525,244 |
D/D |
(1,814) |
225,355 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2021-02-22 |
4 |
AS |
$280.66 |
$4,934,118 |
D/D |
(17,436) |
227,169 |
|
31% |
|
Foster James C |
Chairman, President and CEO |
|
2021-02-22 |
4 |
OE |
$144.67 |
$2,522,466 |
D/D |
17,436 |
244,605 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2021-02-22 |
4 |
D |
$289.55 |
$91,787 |
D/D |
(317) |
17,883 |
|
- |
|
2062 Records found
|
|
Page 15 of 83 |
|
|